cancer_type	qtl_type	tag_SNP	LD	SNP_id	gene_id	gene_symbol	t-stat	p-value	beta	r	Traits	SNP_position	Gene_position
LAML	cis	rs5769707	0.967	rs739241	MIMAT0018089	hsa-miR-3667-5p	-8.69	1.68e-13	-0.91	-0.68	Monocyte count;Monocyte percentage of white cells;	chr22:49659273	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.935	rs5770594	MIMAT0018089	hsa-miR-3667-5p	-8.01	4.21e-12	-0.85	-0.65	Monocyte count;Monocyte percentage of white cells;	chr22:49624849	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.967	rs4524218	MIMAT0018089	hsa-miR-3667-5p	-8.01	4.21e-12	-0.85	-0.65	Monocyte count;Monocyte percentage of white cells;	chr22:49624991	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.967	rs739248	MIMAT0018089	hsa-miR-3667-5p	-8.01	4.21e-12	-0.85	-0.65	Monocyte count;Monocyte percentage of white cells;	chr22:49631557	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.967	rs2071904	MIMAT0018089	hsa-miR-3667-5p	-7.98	4.82e-12	-0.86	-0.65	Monocyte count;Monocyte percentage of white cells;	chr22:49640829	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.967	rs8141807	MIMAT0018089	hsa-miR-3667-5p	-7.93	6.13e-12	-0.86	-0.64	Monocyte count;Monocyte percentage of white cells;	chr22:49650090	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.935	rs9616332	MIMAT0018089	hsa-miR-3667-5p	-7.93	6.13e-12	-0.86	-0.64	Monocyte count;Monocyte percentage of white cells;	chr22:49654030	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.935	rs739239	MIMAT0018089	hsa-miR-3667-5p	-7.93	6.13e-12	-0.86	-0.64	Monocyte count;Monocyte percentage of white cells;	chr22:49656820	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.874	rs9616714	MIMAT0018089	hsa-miR-3667-5p	-7.93	6.13e-12	-0.86	-0.64	Monocyte count;Monocyte percentage of white cells;	chr22:49657211	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.846	rs5770610	MIMAT0018089	hsa-miR-3667-5p	-7.89	7.43e-12	-0.86	-0.64	Monocyte count;Monocyte percentage of white cells;	chr22:49643249	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.967	rs9616701	MIMAT0018089	hsa-miR-3667-5p	-7.83	9.8e-12	-0.85	-0.64	Monocyte count;Monocyte percentage of white cells;	chr22:49631898	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.967	rs9616713	MIMAT0018089	hsa-miR-3667-5p	-7.77	1.27e-11	-0.86	-0.64	Monocyte count;Monocyte percentage of white cells;	chr22:49655461	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.967	rs763126	MIMAT0018089	hsa-miR-3667-5p	7.65	2.27e-11	0.83	0.63	Monocyte count;Monocyte percentage of white cells;	chr22:49594926	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.521	rs739244	MIMAT0018089	hsa-miR-3667-5p	-7.61	2.69e-11	-0.91	-0.63	Monocyte count;Monocyte percentage of white cells;	chr22:49666510	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.935	rs1109320	MIMAT0018089	hsa-miR-3667-5p	-7.61	2.72e-11	-0.83	-0.63	Monocyte count;Monocyte percentage of white cells;	chr22:49595458	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.967	rs17182154	MIMAT0018089	hsa-miR-3667-5p	-7.6	2.82e-11	-0.82	-0.63	Monocyte count;Monocyte percentage of white cells;	chr22:49596822	chr22:49543437~49543458:-
LAML	cis	rs5769707	1	rs5769707	MIMAT0018089	hsa-miR-3667-5p	-7.6	2.9e-11	-0.85	-0.63	Monocyte count;Monocyte percentage of white cells;	chr22:49619754	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.749	rs7286706	MIMAT0018089	hsa-miR-3667-5p	-7.59	3.02e-11	-0.77	-0.63	Monocyte count;Monocyte percentage of white cells;	chr22:49664698	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.839	rs73176988	MIMAT0018089	hsa-miR-3667-5p	-7.59	3.04e-11	-0.83	-0.63	Monocyte count;Monocyte percentage of white cells;	chr22:49596001	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.542	rs739242	MIMAT0018089	hsa-miR-3667-5p	-7.58	3.07e-11	-0.91	-0.63	Monocyte count;Monocyte percentage of white cells;	chr22:49663468	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.521	rs7285764	MIMAT0018089	hsa-miR-3667-5p	-7.58	3.07e-11	-0.91	-0.63	Monocyte count;Monocyte percentage of white cells;	chr22:49664913	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.521	rs9616715	MIMAT0018089	hsa-miR-3667-5p	-7.58	3.07e-11	-0.91	-0.63	Monocyte count;Monocyte percentage of white cells;	chr22:49664934	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.521	rs6009805	MIMAT0018089	hsa-miR-3667-5p	-7.58	3.07e-11	-0.91	-0.63	Monocyte count;Monocyte percentage of white cells;	chr22:49665067	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.521	rs6009807	MIMAT0018089	hsa-miR-3667-5p	-7.58	3.07e-11	-0.91	-0.63	Monocyte count;Monocyte percentage of white cells;	chr22:49665274	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.521	rs5769719	MIMAT0018089	hsa-miR-3667-5p	-7.56	3.39e-11	-0.9	-0.63	Monocyte count;Monocyte percentage of white cells;	chr22:49668453	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.521	rs5769720	MIMAT0018089	hsa-miR-3667-5p	-7.56	3.39e-11	-0.9	-0.63	Monocyte count;Monocyte percentage of white cells;	chr22:49668485	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.521	rs5770633	MIMAT0018089	hsa-miR-3667-5p	-7.56	3.39e-11	-0.9	-0.63	Monocyte count;Monocyte percentage of white cells;	chr22:49668779	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.777	rs739243	MIMAT0018089	hsa-miR-3667-5p	-7.47	5.17e-11	-0.77	-0.62	Monocyte count;Monocyte percentage of white cells;	chr22:49663563	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.732	rs135865	MIMAT0018089	hsa-miR-3667-5p	-7.46	5.59e-11	-0.81	-0.62	Monocyte count;Monocyte percentage of white cells;	chr22:49611181	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.622	rs2018467	MIMAT0018089	hsa-miR-3667-5p	-7.45	5.88e-11	-0.76	-0.62	Monocyte count;Monocyte percentage of white cells;	chr22:49670631	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.521	rs6009810	MIMAT0018089	hsa-miR-3667-5p	-7.45	5.88e-11	-0.89	-0.62	Monocyte count;Monocyte percentage of white cells;	chr22:49665892	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.967	rs2187891	MIMAT0018089	hsa-miR-3667-5p	-7.39	7.79e-11	-0.81	-0.62	Monocyte count;Monocyte percentage of white cells;	chr22:49600446	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.706	rs763128	MIMAT0018089	hsa-miR-3667-5p	-7.38	8.16e-11	-0.89	-0.62	Monocyte count;Monocyte percentage of white cells;	chr22:49624397	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.837	rs5769709	MIMAT0018089	hsa-miR-3667-5p	-7.36	8.61e-11	-0.9	-0.62	Monocyte count;Monocyte percentage of white cells;	chr22:49628109	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.749	rs3884944	MIMAT0018089	hsa-miR-3667-5p	-7.34	9.48e-11	-0.76	-0.61	Monocyte count;Monocyte percentage of white cells;	chr22:49669348	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.681	rs135879	MIMAT0018089	hsa-miR-3667-5p	-7.3	1.14e-10	-0.89	-0.61	Monocyte count;Monocyte percentage of white cells;	chr22:49625003	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.642	rs135880	MIMAT0018089	hsa-miR-3667-5p	-7.3	1.14e-10	-0.89	-0.61	Monocyte count;Monocyte percentage of white cells;	chr22:49625006	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.967	rs763127	MIMAT0018089	hsa-miR-3667-5p	-7.29	1.19e-10	-0.79	-0.61	Monocyte count;Monocyte percentage of white cells;	chr22:49612430	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.837	rs5770599	MIMAT0018089	hsa-miR-3667-5p	-7.29	1.22e-10	-0.89	-0.61	Monocyte count;Monocyte percentage of white cells;	chr22:49626333	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.777	rs5770622	MIMAT0018089	hsa-miR-3667-5p	-7.18	2.05e-10	-0.81	-0.61	Monocyte count;Monocyte percentage of white cells;	chr22:49657900	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.568	rs2011097	MIMAT0018089	hsa-miR-3667-5p	-7.16	2.25e-10	-0.89	-0.6	Monocyte count;Monocyte percentage of white cells;	chr22:49624421	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.681	rs9616329	MIMAT0018089	hsa-miR-3667-5p	-7.11	2.85e-10	-0.87	-0.6	Monocyte count;Monocyte percentage of white cells;	chr22:49632666	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.967	rs5769698	MIMAT0018089	hsa-miR-3667-5p	-7.09	3.06e-10	-0.77	-0.6	Monocyte count;Monocyte percentage of white cells;	chr22:49604058	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.706	rs2071903	MIMAT0018089	hsa-miR-3667-5p	-7.06	3.51e-10	-0.92	-0.6	Monocyte count;Monocyte percentage of white cells;	chr22:49640869	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.681	rs4824068	MIMAT0018089	hsa-miR-3667-5p	-7.05	3.68e-10	-0.9	-0.6	Monocyte count;Monocyte percentage of white cells;	chr22:49631153	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.967	rs5770585	MIMAT0018089	hsa-miR-3667-5p	-7.02	4.29e-10	-0.8	-0.6	Monocyte count;Monocyte percentage of white cells;	chr22:49614226	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.967	rs9616327	MIMAT0018089	hsa-miR-3667-5p	-6.95	5.73e-10	-0.8	-0.59	Monocyte count;Monocyte percentage of white cells;	chr22:49617243	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.632	rs6009782	MIMAT0018089	hsa-miR-3667-5p	-6.86	8.62e-10	-0.86	-0.59	Monocyte count;Monocyte percentage of white cells;	chr22:49617164	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.592	rs6009783	MIMAT0018089	hsa-miR-3667-5p	-6.86	8.62e-10	-0.86	-0.59	Monocyte count;Monocyte percentage of white cells;	chr22:49617353	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.656	rs135875	MIMAT0018089	hsa-miR-3667-5p	-6.86	8.62e-10	-0.86	-0.59	Monocyte count;Monocyte percentage of white cells;	chr22:49618771	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.632	rs5770601	MIMAT0018089	hsa-miR-3667-5p	-6.86	8.9e-10	-0.89	-0.59	Monocyte count;Monocyte percentage of white cells;	chr22:49628255	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.605	rs6009791	MIMAT0018089	hsa-miR-3667-5p	-6.84	9.52e-10	-0.9	-0.59	Monocyte count;Monocyte percentage of white cells;	chr22:49631617	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.605	rs9616702	MIMAT0018089	hsa-miR-3667-5p	-6.84	9.52e-10	-0.9	-0.59	Monocyte count;Monocyte percentage of white cells;	chr22:49632290	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.667	rs4824069	MIMAT0018089	hsa-miR-3667-5p	-6.81	1.12e-09	-0.9	-0.59	Monocyte count;Monocyte percentage of white cells;	chr22:49636677	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.967	rs2051626	MIMAT0018089	hsa-miR-3667-5p	-6.73	1.58e-09	-0.8	-0.58	Monocyte count;Monocyte percentage of white cells;	chr22:49615325	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.967	rs1018812	MIMAT0018089	hsa-miR-3667-5p	-6.73	1.58e-09	-0.8	-0.58	Monocyte count;Monocyte percentage of white cells;	chr22:49616425	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.632	rs135871	MIMAT0018089	hsa-miR-3667-5p	-6.67	2.13e-09	-0.85	-0.58	Monocyte count;Monocyte percentage of white cells;	chr22:49615321	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.632	rs135876	MIMAT0018089	hsa-miR-3667-5p	-6.64	2.36e-09	-0.85	-0.58	Monocyte count;Monocyte percentage of white cells;	chr22:49619925	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.609	rs2071890	MIMAT0018089	hsa-miR-3667-5p	-6.61	2.81e-09	-0.83	-0.57	Monocyte count;Monocyte percentage of white cells;	chr22:49607643	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.609	rs739247	MIMAT0018089	hsa-miR-3667-5p	-6.45	5.59e-09	-0.81	-0.56	Monocyte count;Monocyte percentage of white cells;	chr22:49603009	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.609	rs135861	MIMAT0018089	hsa-miR-3667-5p	-6.45	5.59e-09	-0.81	-0.56	Monocyte count;Monocyte percentage of white cells;	chr22:49604470	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.609	rs2007024	MIMAT0018089	hsa-miR-3667-5p	-6.41	6.9e-09	-0.8	-0.56	Monocyte count;Monocyte percentage of white cells;	chr22:49595167	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.933	rs2157444	MIMAT0018089	hsa-miR-3667-5p	-6.34	9.1e-09	-0.75	-0.56	Monocyte count;Monocyte percentage of white cells;	chr22:49600644	chr22:49543437~49543458:-
LAML	cis	rs5769707	0.632	rs1476037	MIMAT0018089	hsa-miR-3667-5p	-6.24	1.44e-08	-0.8	-0.55	Monocyte count;Monocyte percentage of white cells;	chr22:49597729	chr22:49543437~49543458:-
LAML	cis	rs2910162	0.865	rs6878034	MIMAT0004608	hsa-miR-146a-3p	6.2	1.73e-08	0.67	0.55	Allergic disease (asthma, hay fever or eczema);	chr5:160488114	chr5:160485408~160485429:+
LAML	cis	rs2910162	0.865	rs4921142	MIMAT0004608	hsa-miR-146a-3p	6.2	1.73e-08	0.67	0.55	Allergic disease (asthma, hay fever or eczema);	chr5:160490208	chr5:160485408~160485429:+
LAML	cis	rs2910162	0.865	rs5010836	MIMAT0004608	hsa-miR-146a-3p	6.2	1.73e-08	0.67	0.55	Allergic disease (asthma, hay fever or eczema);	chr5:160492159	chr5:160485408~160485429:+
LAML	cis	rs2910162	0.865	rs4921291	MIMAT0004608	hsa-miR-146a-3p	6.2	1.73e-08	0.67	0.55	Allergic disease (asthma, hay fever or eczema);	chr5:160493288	chr5:160485408~160485429:+
LAML	cis	rs5769707	0.554	rs10854876	MIMAT0018089	hsa-miR-3667-5p	-6.1	2.68e-08	-0.84	-0.54	Monocyte count;Monocyte percentage of white cells;	chr22:49616922	chr22:49543437~49543458:-
LAML	cis	rs75358501	0.636	rs888621	MIMAT0014995	hsa-miR-3130-5p	6.02	3.9e-08	0.63	0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.636	rs888621	MIMAT0014995_1	hsa-miR-3130-5p	6.02	3.9e-08	0.63	0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783246~206783266:+
LAML	cis	rs75358501	0.688	rs2287629	MIMAT0014995	hsa-miR-3130-5p	6.02	3.9e-08	0.63	0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.688	rs2287629	MIMAT0014995_1	hsa-miR-3130-5p	6.02	3.9e-08	0.63	0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783246~206783266:+
LAML	cis	rs75358501	0.636	rs725980	MIMAT0014995	hsa-miR-3130-5p	-6.02	3.9e-08	-0.63	-0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.636	rs725980	MIMAT0014995_1	hsa-miR-3130-5p	-6.02	3.9e-08	-0.63	-0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783246~206783266:+
LAML	cis	rs75358501	0.636	rs12471008	MIMAT0014995	hsa-miR-3130-5p	-6.02	3.9e-08	-0.63	-0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.636	rs12471008	MIMAT0014995_1	hsa-miR-3130-5p	-6.02	3.9e-08	-0.63	-0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783246~206783266:+
LAML	cis	rs75358501	0.636	rs768533	MIMAT0014995	hsa-miR-3130-5p	-6.02	3.9e-08	-0.63	-0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.636	rs768533	MIMAT0014995_1	hsa-miR-3130-5p	-6.02	3.9e-08	-0.63	-0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783246~206783266:+
LAML	cis	rs75358501	0.636	rs13427002	MIMAT0014995	hsa-miR-3130-5p	-6.02	3.9e-08	-0.63	-0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.636	rs13427002	MIMAT0014995_1	hsa-miR-3130-5p	-6.02	3.9e-08	-0.63	-0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783246~206783266:+
LAML	cis	rs75358501	0.636	rs2241347	MIMAT0014995	hsa-miR-3130-5p	-6.02	3.9e-08	-0.63	-0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.636	rs2241347	MIMAT0014995_1	hsa-miR-3130-5p	-6.02	3.9e-08	-0.63	-0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783246~206783266:+
LAML	cis	rs75358501	0.636	rs7576591	MIMAT0014995	hsa-miR-3130-5p	-6.02	3.9e-08	-0.63	-0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.636	rs7576591	MIMAT0014995_1	hsa-miR-3130-5p	-6.02	3.9e-08	-0.63	-0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783246~206783266:+
LAML	cis	rs75358501	0.636	rs2287628	MIMAT0014995	hsa-miR-3130-5p	-6.02	3.9e-08	-0.63	-0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.636	rs2287628	MIMAT0014995_1	hsa-miR-3130-5p	-6.02	3.9e-08	-0.63	-0.54	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783246~206783266:+
LAML	cis	rs5769707	0.632	rs135877	MIMAT0018089	hsa-miR-3667-5p	-5.97	4.86e-08	-0.78	-0.53	Monocyte count;Monocyte percentage of white cells;	chr22:49620354	chr22:49543437~49543458:-
LAML	cis	rs75358501	0.636	rs16838834	MIMAT0014995	hsa-miR-3130-5p	-5.94	5.33e-08	-0.68	-0.53	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.636	rs16838834	MIMAT0014995_1	hsa-miR-3130-5p	-5.94	5.33e-08	-0.68	-0.53	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783246~206783266:+
LAML	cis	rs75358501	0.688	rs28365797	MIMAT0014995	hsa-miR-3130-5p	-5.94	5.33e-08	-0.68	-0.53	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.688	rs28365797	MIMAT0014995_1	hsa-miR-3130-5p	-5.94	5.33e-08	-0.68	-0.53	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783246~206783266:+
LAML	cis	rs75358501	0.636	rs7580138	MIMAT0014995	hsa-miR-3130-5p	-5.86	7.67e-08	-0.62	-0.53	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.636	rs7580138	MIMAT0014995_1	hsa-miR-3130-5p	-5.86	7.67e-08	-0.62	-0.53	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783246~206783266:+
LAML	cis	rs75358501	0.636	rs10199766	MIMAT0014995	hsa-miR-3130-5p	-5.85	7.9e-08	-0.62	-0.53	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.636	rs10199766	MIMAT0014995_1	hsa-miR-3130-5p	-5.85	7.9e-08	-0.62	-0.53	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783246~206783266:+
LAML	cis	rs1712517	0.524	rs4917384	MIMAT0005951	hsa-miR-1307-3p	5.8	1.01e-07	0.36	0.52	Migraine;	chr10:103236031	chr10:103394301~103394322:-
LAML	cis	rs2910162	0.865	rs6887783	MIMAT0004608	hsa-miR-146a-3p	5.73	1.38e-07	0.64	0.52	Allergic disease (asthma, hay fever or eczema);	chr5:160495202	chr5:160485408~160485429:+
LAML	cis	rs5769707	0.616	rs135869	MIMAT0018089	hsa-miR-3667-5p	-5.7	1.56e-07	-0.78	-0.52	Monocyte count;Monocyte percentage of white cells;	chr22:49614718	chr22:49543437~49543458:-
LAML	cis	rs75358501	0.636	rs3815686	MIMAT0014995	hsa-miR-3130-5p	-5.68	1.66e-07	-0.65	-0.52	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.636	rs3815686	MIMAT0014995_1	hsa-miR-3130-5p	-5.68	1.66e-07	-0.65	-0.52	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783246~206783266:+
LAML	cis	rs75358501	0.636	rs11895370	MIMAT0014995	hsa-miR-3130-5p	-5.68	1.66e-07	-0.65	-0.52	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.636	rs11895370	MIMAT0014995_1	hsa-miR-3130-5p	-5.68	1.66e-07	-0.65	-0.52	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783246~206783266:+
LAML	cis	rs5769707	0.656	rs135878	MIMAT0018089	hsa-miR-3667-5p	-5.67	1.76e-07	-0.79	-0.52	Monocyte count;Monocyte percentage of white cells;	chr22:49620721	chr22:49543437~49543458:-
LAML	cis	rs75358501	0.584	rs11894165	MIMAT0014995	hsa-miR-3130-5p	-5.64	1.96e-07	-0.6	-0.51	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.584	rs11894165	MIMAT0014995_1	hsa-miR-3130-5p	-5.64	1.96e-07	-0.6	-0.51	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783246~206783266:+
LAML	cis	rs75358501	0.688	rs1862087	MIMAT0014995	hsa-miR-3130-5p	-5.64	1.96e-07	-0.6	-0.51	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.688	rs1862087	MIMAT0014995_1	hsa-miR-3130-5p	-5.64	1.96e-07	-0.6	-0.51	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783246~206783266:+
LAML	cis	rs75358501	0.636	rs1862089	MIMAT0014995	hsa-miR-3130-5p	-5.64	1.99e-07	-0.6	-0.51	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.636	rs1862089	MIMAT0014995_1	hsa-miR-3130-5p	-5.64	1.99e-07	-0.6	-0.51	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783246~206783266:+
LAML	cis	rs75358501	0.636	rs10932164	MIMAT0014995	hsa-miR-3130-5p	-5.62	2.19e-07	-0.6	-0.51	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.636	rs10932164	MIMAT0014995_1	hsa-miR-3130-5p	-5.62	2.19e-07	-0.6	-0.51	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783246~206783266:+
LAML	cis	rs1712517	0.524	rs1712509	MIMAT0005951	hsa-miR-1307-3p	-5.61	2.27e-07	-0.35	-0.51	Migraine;	chr10:103254113	chr10:103394301~103394322:-
LAML	cis	rs4917385	1	rs4917385	MIMAT0005951	hsa-miR-1307-3p	5.61	2.27e-07	0.35	0.51	Systemic lupus erythematosus;	chr10:103243964	chr10:103394301~103394322:-
LAML	cis	rs2910162	1	rs2961919	MIMAT0004608	hsa-miR-146a-3p	-5.57	2.66e-07	-0.62	-0.51	Allergic disease (asthma, hay fever or eczema);	chr5:160476127	chr5:160485408~160485429:+
LAML	cis	rs2910162	1	rs2910162	MIMAT0004608	hsa-miR-146a-3p	-5.57	2.72e-07	-0.62	-0.51	Allergic disease (asthma, hay fever or eczema);	chr5:160482338	chr5:160485408~160485429:+
LAML	cis	rs1712517	0.566	rs1163073	MIMAT0005951	hsa-miR-1307-3p	5.53	3.18e-07	0.35	0.51	Migraine;	chr10:103263177	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.525	rs7911488	MIMAT0005951	hsa-miR-1307-3p	-5.49	3.83e-07	-0.34	-0.5	Migraine;	chr10:103394332	chr10:103394301~103394322:-
LAML	cis	rs6009824	0.545	rs5770659	MIMAT0018089	hsa-miR-3667-5p	-5.42	5.03e-07	-0.7	-0.5	Natriuretic peptide levels;	chr22:49690204	chr22:49543437~49543458:-
LAML	cis	rs1712517	0.566	rs7076274	MIMAT0005951	hsa-miR-1307-3p	-5.41	5.31e-07	-0.34	-0.5	Migraine;	chr10:103286250	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.545	rs3740381	MIMAT0005951	hsa-miR-1307-3p	-5.41	5.31e-07	-0.34	-0.5	Migraine;	chr10:103286932	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.566	rs7917388	MIMAT0005951	hsa-miR-1307-3p	-5.41	5.31e-07	-0.34	-0.5	Migraine;	chr10:103295206	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.525	rs11191642	MIMAT0005951	hsa-miR-1307-3p	-5.41	5.31e-07	-0.34	-0.5	Migraine;	chr10:103296155	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.588	rs12220267	MIMAT0005951	hsa-miR-1307-3p	-5.41	5.31e-07	-0.34	-0.5	Migraine;	chr10:103315955	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.503	rs72846198	MIMAT0005951	hsa-miR-1307-3p	-5.41	5.31e-07	-0.34	-0.5	Migraine;	chr10:103338267	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.526	rs113528138	MIMAT0005951	hsa-miR-1307-3p	-5.41	5.31e-07	-0.34	-0.5	Migraine;	chr10:103365694	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.525	rs11191667	MIMAT0005951	hsa-miR-1307-3p	-5.41	5.31e-07	-0.34	-0.5	Migraine;	chr10:103369141	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.525	rs2271751	MIMAT0005951	hsa-miR-1307-3p	-5.41	5.31e-07	-0.34	-0.5	Migraine;	chr10:103415374	chr10:103394301~103394322:-
LAML	cis	rs2910162	1	rs888656	MIMAT0004608	hsa-miR-146a-3p	-5.4	5.49e-07	-0.61	-0.5	Allergic disease (asthma, hay fever or eczema);	chr5:160476863	chr5:160485408~160485429:+
LAML	cis	rs75358501	0.636	rs57600974	MIMAT0014995	hsa-miR-3130-5p	-5.17	1.42e-06	-0.63	-0.48	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.636	rs57600974	MIMAT0014995_1	hsa-miR-3130-5p	-5.17	1.42e-06	-0.63	-0.48	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783246~206783266:+
LAML	cis	rs75358501	0.636	rs4673363	MIMAT0014995	hsa-miR-3130-5p	-5.11	1.79e-06	-0.62	-0.48	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.636	rs4673363	MIMAT0014995_1	hsa-miR-3130-5p	-5.11	1.79e-06	-0.62	-0.48	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783246~206783266:+
LAML	cis	rs75358501	0.636	rs12478466	MIMAT0014995	hsa-miR-3130-5p	-5.1	1.89e-06	-0.61	-0.48	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.636	rs12478466	MIMAT0014995_1	hsa-miR-3130-5p	-5.1	1.89e-06	-0.61	-0.48	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783246~206783266:+
LAML	cis	rs75358501	0.636	rs957414	MIMAT0014995	hsa-miR-3130-5p	-5.08	2.1e-06	-0.62	-0.47	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783276~206783296:-
LAML	cis	rs75358501	0.636	rs957414	MIMAT0014995_1	hsa-miR-3130-5p	-5.08	2.1e-06	-0.62	-0.47	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783246~206783266:+
LAML	cis	rs7894407	0.504	rs7089271	MIMAT0022727	hsa-miR-1307-5p	-4.82	5.8e-06	-0.41	-0.46	White matter hyperintensity burden;	chr10:103417157	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.836	rs7093039	MIMAT0022727	hsa-miR-1307-5p	-4.74	8.2e-06	-0.41	-0.45	Migraine;	chr10:103389790	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.904	rs7905968	MIMAT0022727	hsa-miR-1307-5p	-4.74	8.21e-06	-0.41	-0.45	Migraine;	chr10:103375562	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.844	rs1163075	MIMAT0005951	hsa-miR-1307-3p	4.68	1.03e-05	0.29	0.44	Migraine;	chr10:103261506	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.844	rs1163074	MIMAT0005951	hsa-miR-1307-3p	-4.68	1.03e-05	-0.29	-0.44	Migraine;	chr10:103262005	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.844	rs1163081	MIMAT0005951	hsa-miR-1307-3p	-4.68	1.03e-05	-0.29	-0.44	Migraine;	chr10:103270083	chr10:103394301~103394322:-
LAML	cis	rs8103278	0.706	rs3810333	MIMAT0004693	hsa-miR-330-5p	-4.67	1.04e-05	-0.44	-0.44	Coronary artery disease;	chr19:45815433	chr19:45639049~45639070:-
LAML	cis	rs1712517	0.844	rs4918003	MIMAT0005951	hsa-miR-1307-3p	-4.67	1.06e-05	-0.29	-0.44	Migraine;	chr10:103284400	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.904	rs10883863	MIMAT0022727	hsa-miR-1307-5p	4.66	1.08e-05	0.4	0.44	Migraine;	chr10:103402122	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.873	rs1163083	MIMAT0005951	hsa-miR-1307-3p	-4.66	1.09e-05	-0.29	-0.44	Migraine;	chr10:103278698	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.844	rs1163087	MIMAT0005951	hsa-miR-1307-3p	-4.63	1.23e-05	-0.28	-0.44	Migraine;	chr10:103283532	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.787	rs1163089	MIMAT0005951	hsa-miR-1307-3p	-4.63	1.23e-05	-0.28	-0.44	Migraine;	chr10:103284207	chr10:103394301~103394322:-
LAML	cis	rs1712517	1	rs1712517	MIMAT0005951	hsa-miR-1307-3p	-4.61	1.35e-05	-0.29	-0.44	Migraine;	chr10:103273258	chr10:103394301~103394322:-
LAML	cis	rs1712517	1	rs3123794	MIMAT0005951	hsa-miR-1307-3p	-4.61	1.35e-05	-0.29	-0.44	Migraine;	chr10:103273985	chr10:103394301~103394322:-
LAML	cis	rs1712517	1	rs1163084	MIMAT0005951	hsa-miR-1307-3p	-4.61	1.35e-05	-0.29	-0.44	Migraine;	chr10:103279291	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.873	rs1712516	MIMAT0005951	hsa-miR-1307-3p	-4.59	1.44e-05	-0.28	-0.44	Migraine;	chr10:103273871	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.873	rs1163086	MIMAT0005951	hsa-miR-1307-3p	-4.59	1.44e-05	-0.28	-0.44	Migraine;	chr10:103279822	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.771	rs61871160	MIMAT0005951	hsa-miR-1307-3p	-4.52	1.9e-05	-0.28	-0.43	Migraine;	chr10:103384531	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.904	rs6584547	MIMAT0022727	hsa-miR-1307-5p	-4.52	1.9e-05	-0.39	-0.43	Migraine;	chr10:103305652	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.904	rs4918007	MIMAT0022727	hsa-miR-1307-5p	4.49	2.12e-05	0.39	0.43	Migraine;	chr10:103347713	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.836	rs11191649	MIMAT0022727	hsa-miR-1307-5p	-4.49	2.12e-05	-0.39	-0.43	Migraine;	chr10:103307280	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.771	rs59744322	MIMAT0005951	hsa-miR-1307-3p	-4.48	2.24e-05	-0.27	-0.43	Migraine;	chr10:103386935	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.771	rs11191676	MIMAT0005951	hsa-miR-1307-3p	-4.48	2.24e-05	-0.27	-0.43	Migraine;	chr10:103395309	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.771	rs2292807	MIMAT0005951	hsa-miR-1307-3p	-4.48	2.24e-05	-0.27	-0.43	Migraine;	chr10:103395888	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.771	rs11191672	MIMAT0005951	hsa-miR-1307-3p	-4.48	2.25e-05	-0.27	-0.43	Migraine;	chr10:103379204	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.74	rs4917387	MIMAT0005951	hsa-miR-1307-3p	-4.47	2.26e-05	-0.27	-0.43	Migraine;	chr10:103348698	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.771	rs7921655	MIMAT0005951	hsa-miR-1307-3p	-4.47	2.26e-05	-0.27	-0.43	Migraine;	chr10:103353944	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.771	rs7074749	MIMAT0005951	hsa-miR-1307-3p	-4.47	2.26e-05	-0.27	-0.43	Migraine;	chr10:103356299	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.74	rs11191663	MIMAT0005951	hsa-miR-1307-3p	-4.47	2.26e-05	-0.27	-0.43	Migraine;	chr10:103358705	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.771	rs11191664	MIMAT0005951	hsa-miR-1307-3p	-4.47	2.26e-05	-0.27	-0.43	Migraine;	chr10:103358719	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.771	rs11191666	MIMAT0005951	hsa-miR-1307-3p	-4.47	2.26e-05	-0.27	-0.43	Migraine;	chr10:103367521	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.771	rs10883857	MIMAT0005951	hsa-miR-1307-3p	4.47	2.26e-05	0.27	0.43	Migraine;	chr10:103367830	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.771	rs10883858	MIMAT0005951	hsa-miR-1307-3p	-4.47	2.26e-05	-0.27	-0.43	Migraine;	chr10:103367951	chr10:103394301~103394322:-
LAML	cis	rs7839435	1	rs11780592	MIMAT0027587	hsa-miR-6842-3p	-4.47	2.3e-05	-0.48	-0.43	Lung adenocarcinoma;	chr8:27561230	chr8:27433413~27433434:+
LAML	cis	rs1712517	0.904	rs7905968	MIMAT0005951	hsa-miR-1307-3p	-4.47	2.31e-05	-0.27	-0.43	Migraine;	chr10:103375562	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.836	rs7093039	MIMAT0005951	hsa-miR-1307-3p	-4.46	2.36e-05	-0.27	-0.43	Migraine;	chr10:103389790	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.74	rs11191643	MIMAT0005951	hsa-miR-1307-3p	-4.45	2.5e-05	-0.27	-0.43	Migraine;	chr10:103297804	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.773	rs1063461	MIMAT0005951	hsa-miR-1307-3p	-4.44	2.58e-05	-0.27	-0.43	Migraine;	chr10:103289348	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.74	rs4293062	MIMAT0005951	hsa-miR-1307-3p	-4.44	2.58e-05	-0.27	-0.43	Migraine;	chr10:103292867	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.744	rs11191641	MIMAT0005951	hsa-miR-1307-3p	-4.44	2.58e-05	-0.27	-0.43	Migraine;	chr10:103293183	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.744	rs4293063	MIMAT0005951	hsa-miR-1307-3p	-4.44	2.58e-05	-0.27	-0.43	Migraine;	chr10:103293219	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.771	rs2008530	MIMAT0005951	hsa-miR-1307-3p	-4.44	2.58e-05	-0.27	-0.43	Migraine;	chr10:103299082	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.773	rs1063461	MIMAT0022727	hsa-miR-1307-5p	-4.44	2.61e-05	-0.38	-0.43	Migraine;	chr10:103289348	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.74	rs4293062	MIMAT0022727	hsa-miR-1307-5p	-4.44	2.61e-05	-0.38	-0.43	Migraine;	chr10:103292867	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.744	rs11191641	MIMAT0022727	hsa-miR-1307-5p	-4.44	2.61e-05	-0.38	-0.43	Migraine;	chr10:103293183	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.744	rs4293063	MIMAT0022727	hsa-miR-1307-5p	-4.44	2.61e-05	-0.38	-0.43	Migraine;	chr10:103293219	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.771	rs2008530	MIMAT0022727	hsa-miR-1307-5p	-4.44	2.61e-05	-0.38	-0.43	Migraine;	chr10:103299082	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.771	rs11191645	MIMAT0005951	hsa-miR-1307-3p	-4.43	2.65e-05	-0.27	-0.43	Migraine;	chr10:103299551	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.771	rs61350103	MIMAT0005951	hsa-miR-1307-3p	-4.43	2.65e-05	-0.27	-0.43	Migraine;	chr10:103309363	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.771	rs11191654	MIMAT0005951	hsa-miR-1307-3p	-4.43	2.65e-05	-0.27	-0.43	Migraine;	chr10:103317367	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.771	rs61869827	MIMAT0005951	hsa-miR-1307-3p	-4.43	2.65e-05	-0.27	-0.43	Migraine;	chr10:103319682	chr10:103394301~103394322:-
LAML	cis	rs76525880	0.619	rs2288277	MIMAT0004555	hsa-miR-10a-3p	4.42	2.77e-05	0.62	0.42	Colorectal or endometrial cancer;	chr17:48573699	chr17:48579864~48579885:-
LAML	cis	rs1712517	0.904	rs6584547	MIMAT0005951	hsa-miR-1307-3p	-4.42	2.8e-05	-0.27	-0.42	Migraine;	chr10:103305652	chr10:103394301~103394322:-
LAML	cis	rs1712517	0.771	rs59744322	MIMAT0022727	hsa-miR-1307-5p	-4.41	2.9e-05	-0.38	-0.42	Migraine;	chr10:103386935	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.771	rs11191676	MIMAT0022727	hsa-miR-1307-5p	-4.41	2.9e-05	-0.38	-0.42	Migraine;	chr10:103395309	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.771	rs2292807	MIMAT0022727	hsa-miR-1307-5p	-4.41	2.9e-05	-0.38	-0.42	Migraine;	chr10:103395888	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.74	rs4917387	MIMAT0022727	hsa-miR-1307-5p	-4.41	2.9e-05	-0.38	-0.42	Migraine;	chr10:103348698	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.771	rs7921655	MIMAT0022727	hsa-miR-1307-5p	-4.41	2.9e-05	-0.38	-0.42	Migraine;	chr10:103353944	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.771	rs7074749	MIMAT0022727	hsa-miR-1307-5p	-4.41	2.9e-05	-0.38	-0.42	Migraine;	chr10:103356299	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.74	rs11191663	MIMAT0022727	hsa-miR-1307-5p	-4.41	2.9e-05	-0.38	-0.42	Migraine;	chr10:103358705	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.771	rs11191664	MIMAT0022727	hsa-miR-1307-5p	-4.41	2.9e-05	-0.38	-0.42	Migraine;	chr10:103358719	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.771	rs11191666	MIMAT0022727	hsa-miR-1307-5p	-4.41	2.9e-05	-0.38	-0.42	Migraine;	chr10:103367521	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.771	rs10883858	MIMAT0022727	hsa-miR-1307-5p	-4.41	2.9e-05	-0.38	-0.42	Migraine;	chr10:103367951	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.771	rs10883857	MIMAT0022727	hsa-miR-1307-5p	4.41	2.9e-05	0.38	0.42	Migraine;	chr10:103367830	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.771	rs11191672	MIMAT0022727	hsa-miR-1307-5p	-4.41	2.9e-05	-0.38	-0.42	Migraine;	chr10:103379204	chr10:103394341~103394361:-
LAML	cis	rs1712517	0.771	rs61871160	MIMAT0022727	hsa-miR-1307-5p	-4.36	3.52e-05	-0.38	-0.42	Migraine;	chr10:103384531	chr10:103394341~103394361:-